The Association Between Core Temperature and Health
Launched by SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY ,CHINESE ACADEMY OF SCIENCES · May 21, 2024
Trial Information
Current as of February 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
According to pilot study, we found 4℃ water could significantly reduce core body temperature. Thus, we aim to explore whether 4℃ water drinking could promote body composition and further help to extend lifespan.
Participants will be randomly divided into intervention (drinking 4℃ water at 9a.m., 12p.m., 15p.m., 18p.m.) and control group (drinking 37℃ water at 9a.m., 12p.m., 15p.m., 18p.m.) for 6-month intervention. Tests will be conducted in Shenzhen Institute of Advanced Technology, while checkup will be tested at Health Checkup Department of Shenzhen University General Hospital. Body com...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged between 50 and 65 years old (including 50 and 65)
- • No surgery in the past 6 months
- • Healthy (No metabolic diseases, cardiovascular diseases, lung diseases (COPD, asthma, et al.), endocrine diseases and gastrointestinal diseases)
- • Based in Shenzhen during the whole study period
- • No significant change on body weight in the past 3 months
- Exclusion Criteria:
- • Those who need to take medication for a long term (including diet pills)
- • On a diet
- • Disabled
- • Females who are trying to get pregnant, pregnant, or breastfeeding
- • Presence of a metal implant in the body (e.g. pacemaker)
- • Those with claustrophobia
- • Those with blood phobia, pathological hypotension or hypertension
- • Those who are in other intervention studies
Trial Officials
John R Speakman, PhD
Study Chair
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
About Shenzhen Institutes Of Advanced Technology ,Chinese Academy Of Sciences
The Shenzhen Institutes of Advanced Technology (SIAT), part of the Chinese Academy of Sciences, is a leading research institution dedicated to advancing scientific knowledge and technology across various fields, including biomedical research. SIAT is committed to fostering innovation through interdisciplinary collaboration and state-of-the-art facilities, focusing on the translation of research into practical applications. With a strong emphasis on clinical trials and regulatory compliance, SIAT aims to contribute to the global healthcare landscape by developing novel therapies and solutions that address pressing medical challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shenzhen, Guangdong, China
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0